Literature DB >> 11949879

Role of Rho-associated protein kinase and histamine in lysophosphatidic acid-induced airway hyperresponsiveness in guinea pigs.

Terumasa Hashimoto1, Yuuki Nakano, Miyuki Yamashita, Yang-Il Fang, Hisayuki Ohata, Kazutaka Momose.   

Abstract

Inhalation of oleoyl lysophosphatidic acid (LPA) induced airway hyperresponsiveness to acetylcholine (ACh). In contrast, palmitoyl and stearoyl LPA exerted minimal effects. Airway hyperresponsiveness was inhibited by inhalation of Y-27632, an inhibitor of Rho-associated protein kinase (ROCK). Mepyramine, an H1 histamine receptor antagonist and ketotifen, an inhibitor of histamine release and H1 histamine receptor antagonist, also inhibited airway hyperresponsiveness induced by LPA; however, aspirin failed to attenuate this response. The incubation of lung fragments with LPA gave rise to releases in histamine. On the other hand, LPA produced no significant changes on the smooth muscle contraction evoked by ACh. These findings suggest that LPA-induced airway hyperresponsiveness is attributable to activation of the Rho/ROCK-mediated pathway via endothelial cell differentiation gene (EDG) receptors, probably EDG 7. Moreover, histamine release may be involved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949879     DOI: 10.1254/jjp.88.256

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  7 in total

1.  Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells.

Authors:  Jiro Sakai; Masahiro Oike; Masakazu Hirakawa; Yushi Ito
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

Review 2.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

3.  Lysophospholipids in Lung Inflammatory Diseases.

Authors:  Jing Zhao; Yutong Zhao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Airway smooth muscle as a target of asthma therapy: history and new directions.

Authors:  Luke J Janssen; Kieran Killian
Journal:  Respir Res       Date:  2006-09-29

5.  Efficacy Comparison of LPA2 Antagonist H2L5186303 and Agonist GRI977143 on Ovalbumin-Induced Allergic Asthma in BALB/c Mice.

Authors:  Ye-Ji Lee; Dong-Soon Im
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

6.  Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.

Authors:  Yutong Zhao; Jiankun Tong; Donghong He; Srikanth Pendyala; Berdyshev Evgeny; Jerold Chun; Anne I Sperling; Viswanathan Natarajan
Journal:  Respir Res       Date:  2009-11-20

7.  Eosinophilic inflammation in allergic asthma.

Authors:  Samantha S Possa; Edna A Leick; Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  Front Pharmacol       Date:  2013-04-17       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.